Drug Markets/Acoltremon

Acoltremon

1 NDC across 1 manufacturer|0 Generic,1 Brand

Acoltremon is used to treat dry eye syndromes, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on May 28, 2025.

Acoltremon is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $14.09 to $14.09 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$14.09 – $14.09

per EA

7d Activity

1↓0 flat

avg -0.1% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing ACOLTREMON

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
TRYPTYR 0.003% EYE DROP
$14.0864
per EA
-0.06%

Frequently Asked Questions

What is Acoltremon used to treat?

Acoltremon is used to treat dry eye syndromes, per the National Library of Medicine's MED-RT classification.

How many Acoltremon products are on the market?

The Acoltremon drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Acoltremon?

NADAC reference prices for Acoltremon range from $14.0864 to $14.0864 per EA.

Which manufacturers make Acoltremon?

1 manufacturer lists Acoltremon in NADAC. Ranked by number of NDCs, the largest are Alcon Laboratories, Inc. (1).

How has the price of Acoltremon changed recently?

Over the past 7 days, 0 Acoltremon NDCs rose and 1 fell, with a market-wide average change of -0.1%.